Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Penicka

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Circulation|November 17, 2017
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled TrialTed Feldman, Laura Mauri, Rami Kahwash, et al.
Frontiers in Cardiovascular Medicine|September 30, 2021
Association Among Local Hemodynamic Parameters Derived From CT Angiography and Their Comparable Implications in Development of Acute Coronary SyndromeSeokhun Yang, Gilwoo Choi, Jinlong Zhang, et al.
ESC Heart Failure|October 13, 2018
Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fractionDavid M Kaye, Mark C Petrie, Scott McKenzie, et al.
Clinical Cardiology|March 3, 2021
Rationale and design of the precise percutaneous coronary intervention plan (P3) study: Prospective evaluation of a virtual computed tomography-based percutaneous intervention plannerSakura Nagumo, Carlos Collet, Bjarne L Norgaard, et al.
Journal of Clinical Medicine|September 28, 2023
Mechanical Dyssynchrony Combined with Septal Scarring Reliably Identifies Responders to Cardiac Resynchronization TherapyJürgen Duchenne, Camilla K Larsen, Marta Cvijic, et al.
American Heart Journal|March 21, 2016
Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trialMarko Banovic, Bernard Iung, Jozef Bartunek, et al.
Circulation. Heart Failure|November 18, 2016
One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection FractionDavid M Kaye, Gerd Hasenfuß, Petr Neuzil, et al.
JACC. Cardiovascular Imaging|July 7, 2022
Clinical Validation of a Virtual Planner for Coronary Interventions Based on Coronary CT AngiographyJeroen Sonck, Sakura Nagumo, Bjarne L Norgaard, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 23, 2022
Diagnostic performance of exercise stress tests for detection of epicardial and microvascular coronary artery disease: the UZ Clear studyBert Vandeloo, Daniele Andreini, Sofie Brouwers, et al.
European Heart Journal|September 1, 2024
Aortic valve replacement vs. conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trialMarko Banovic, Svetozar Putnik, Bruno R Da Costa, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Circulation|November 17, 2017
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled TrialTed Feldman, Laura Mauri, Rami Kahwash, et al.
Frontiers in Cardiovascular Medicine|September 30, 2021
Association Among Local Hemodynamic Parameters Derived From CT Angiography and Their Comparable Implications in Development of Acute Coronary SyndromeSeokhun Yang, Gilwoo Choi, Jinlong Zhang, et al.
ESC Heart Failure|October 13, 2018
Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fractionDavid M Kaye, Mark C Petrie, Scott McKenzie, et al.
Clinical Cardiology|March 3, 2021
Rationale and design of the precise percutaneous coronary intervention plan (P3) study: Prospective evaluation of a virtual computed tomography-based percutaneous intervention plannerSakura Nagumo, Carlos Collet, Bjarne L Norgaard, et al.
Journal of Clinical Medicine|September 28, 2023
Mechanical Dyssynchrony Combined with Septal Scarring Reliably Identifies Responders to Cardiac Resynchronization TherapyJürgen Duchenne, Camilla K Larsen, Marta Cvijic, et al.
American Heart Journal|March 21, 2016
Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trialMarko Banovic, Bernard Iung, Jozef Bartunek, et al.
Circulation. Heart Failure|November 18, 2016
One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection FractionDavid M Kaye, Gerd Hasenfuß, Petr Neuzil, et al.
JACC. Cardiovascular Imaging|July 7, 2022
Clinical Validation of a Virtual Planner for Coronary Interventions Based on Coronary CT AngiographyJeroen Sonck, Sakura Nagumo, Bjarne L Norgaard, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 23, 2022
Diagnostic performance of exercise stress tests for detection of epicardial and microvascular coronary artery disease: the UZ Clear studyBert Vandeloo, Daniele Andreini, Sofie Brouwers, et al.
European Heart Journal|September 1, 2024
Aortic valve replacement vs. conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trialMarko Banovic, Svetozar Putnik, Bruno R Da Costa, et al.
Pageof 16